Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.91 +0.72%   SPY: 135.36 +0.13%
Quote Spy DEPO NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


DepoMed (DEPO)

@ 4:00 PM
Click the portfolio to add DEPO:
Close [X]
+ Add DEPO to Portfolio
  
  Last Trade: $6.53 -0.40 (-5.77%)
  Volume: 739,125 126% of avg daily volume
       
  Avg Volume: 584,606
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 6.49 - 7.00
  Open: 6.95
  Previous Close: 6.93
  52-wk Range: 4.20 - 10.19
  Market Cap: 383.3M
  P/E: 4.5
  Div Yield: $0.00 (0.00%)
Indexes
Diabetes Stocks (-2.1%)
Spy DEPO

? Pro holders
? Member holders
? Items submitted
Additional DEPO resources



Customize Links
To see which Pros and tickerspy members own DEPO Sign up now
Latest DEPO Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

American Apparel, Micron, MetLife, TiVo: U.S. Equity Preview
MU  DEPO  BWLD  TIVO  MET  APP  ZGNX  
Linked by Bloomberg - February 05, 12:32PM from (www.bloomberg.com)
Shares of the following companies may have unusual moves in U.S. trading tomorrow. Stock symbols are in parentheses.
 more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Depomed Announces FDA Approval of Merck's JANUMET(R) XR That Accesses Depomed Patents Licensed to Merck
DEPO  
Linked by GlobeNewswire - February 03, 04:15PM from (www.globenewswire.com)
MENLO PARK, Calif., Feb. 3, 2012 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that Merck disclosed on  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Depomed Announces Initiation of Phase 2 Clinical Study in Parkinson's Disease
DEPO  
Linked by GlobeNewswire - January 24, 04:05PM from (www.globenewswire.com)
MENLO PARK, Calif., Jan. 24, 2012 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that it has initiated a  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Depomed Receives Notice of Paragraph IV Certification Against Patents for Gralise(TM)
DEPO  
Linked by GlobeNewswire - January 23, 04:30PM from (www.globenewswire.com)
MENLO PARK, Calif., Jan. 23, 2012 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that it has received a  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Depomed to Present at Lazard Capital Markets Healthcare Conference
DEPO  
Linked by GlobeNewswire - November 08, 04:00PM from (www.globenewswire.com)
MENLO PARK, Calif., Nov. 8, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) announced today that its president and chief  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Depomed Reports Third Quarter 2011 Financial Results
DEPO  
Linked by GlobeNewswire - November 01, 04:01PM from (www.globenewswire.com)
MENLO PARK, Calif., Nov. 1, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today reported financial results for the  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Depomed to Announce Third Quarter 2011 Financial Results on Nov. 1, 2011
DEPO  
Linked by GlobeNewswire - October 26, 04:00PM from (www.globenewswire.com)
MENLO PARK, Calif., Oct. 26, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) announced today that it will release third  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Overbought, But Buy on Dips
MAT  JBHT  DEPO  USU  GOOG  NCMI  
Linked by tickerspy Newswire - October 14, 04:33PM from (www.tickerspy.com)
Stocks ended a strong week on a good note. While consumer confidence may be waning, it sure hasn't stopped consumers from  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Depomed Announces Top-Line Results From Serada(R) Phase 3 Trial BREEZE 3 in Menopausal Hot Flashes
DEPO  
Linked by GlobeNewswire - October 13, 04:00PM from (www.globenewswire.com)
MENLO PARK, Calif., Oct. 13, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced top-line results from BREEZE  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Depomed Announces New Once-Daily GRALISE(TM) Now Available for After-Shingles Pain
DEPO  
Linked by GlobeNewswire - October 10, 01:00PM from (www.globenewswire.com)
MENLO PARK, Calif., Oct. 10, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) announced today that GRALISE(tm) (gabapentin)  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 12



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource